{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:50:29Z","timestamp":1788573029221,"version":"build-2803163510"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1097\/md.0000000000007116","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T15:55:45Z","timestamp":1497455745000},"page":"e7116","source":"Crossref","is-referenced-by-count":64,"title":["Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom"],"prefix":"10.1097","volume":"96","author":[{"given":"Huifang","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhakar","family":"Manne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Shick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Lissoos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210226","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaut.2013.07.005","article-title":"Geoepidemiology of primary sclerosing cholangitis: a critical review","volume":"46","author":"Tanaka","year":"2013","journal-title":"J Autoimmun"},{"key":"R2-17-20210226","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00534-010-0319-8","article-title":"Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"18","author":"Sano","year":"2011","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R3-17-20210226","first-page":"227","article-title":"Primary sclerosing cholangitis in Japanese patients: association with inflammatory bowel disease","volume":"50","author":"Okada","year":"1996","journal-title":"Acta Med Okayama"},{"key":"R4-17-20210226","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/ibd.22938","article-title":"Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease","volume":"18","author":"Boonstra","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"R5-17-20210226","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1478-3231.2011.02614.x","article-title":"Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort","volume":"32","author":"de Valle","year":"2012","journal-title":"Liver Int"},{"key":"R6-17-20210226","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cgh.2011.08.027","article-title":"Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis","volume":"9","author":"Ngu","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R7-17-20210226","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","article-title":"Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"53","author":"Molodecky","year":"2011","journal-title":"Hepatology"},{"key":"R8-17-20210226","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-230X-11-83","article-title":"The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population","volume":"11","author":"Toy","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"R9-17-20210226","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R10-17-20210226","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pds.1115","article-title":"The relationship between time since registration and measured incidence rates in the General Practice Research Database","volume":"14","author":"Lewis","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R12-17-20210226","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1097\/01.ASN.0000092138.65211.71","article-title":"Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study","volume":"14","author":"Jurkovitz","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R16-17-20210226","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/pds.1674","article-title":"Assessing balance in measured baseline covariates when using many-to-one matching on the propensity-score","volume":"17","author":"Austin","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R17-17-20210226","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden","volume":"52","author":"Lindkvist","year":"2010","journal-title":"Hepatology"},{"key":"R18-17-20210226","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jhep.2008.02.017","article-title":"Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study","volume":"48","author":"Card","year":"2008","journal-title":"J Hepatol"},{"key":"R19-17-20210226","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3324\/haematol.2009.017046","article-title":"Pathogenesis and treatment of anemia in inflammatory bowel disease","volume":"95","author":"Weiss","year":"2010","journal-title":"Haematologica"},{"key":"R20-17-20210226","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.3748\/wjg.15.4653","article-title":"Spectrum of anemia associated with chronic liver disease","volume":"15","author":"Gonzalez-Casas","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R21-17-20210226","first-page":"17","article-title":"Prevalence of inflammatory bowel disease among patients with primary sclerosing cholangitis in Iran","volume":"17","author":"Hadizadeh","year":"2016","journal-title":"Arab J"},{"key":"R22-17-20210226","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","article-title":"Natural history and prognostic variables in primary sclerosing cholangitis","volume":"100","author":"Farrant","year":"1991","journal-title":"Gastroenterology"},{"key":"R23-17-20210226","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000007116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T16:25:15Z","timestamp":1750350315000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201706160-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":19,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000007116","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}